Georgianna S. Harris

Person

Tinton Falls, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Toxoplasma gondii cylclic GMP dependent protein kinase G as a chemo...
- Patent number 7,718,390
- Issue date May 18, 2010
- Merial Limited
- Anne Gurnett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Cyclic GMP dependent protein kinase as a chemotherapeutic target fo...
- Patent number 7,125,700
- Issue date Oct 24, 2006
- Merck & Co., Inc.
- Anne Gurnett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Polynucleotide encoding eimeria tenella cGMP dependent protein kinase
- Patent number 6,555,358
- Issue date Apr 29, 2003
- Merck & Co., Inc.
- Anne Gurnett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method of improving in-vitro fertilization
- Patent number 6,352,997
- Issue date Mar 5, 2002
- Merck & Co., Inc.
- Joanne Waldstreicher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Irreversible inhibition of human 5.alpha.-reductase
- Patent number 5,962,442
- Issue date Oct 5, 1999
- Merck & Co., Inc.
- Herb G. Bull
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating polycystic ovary syndrome
- Patent number 5,935,968
- Issue date Aug 10, 1999
- Merck & Co., Inc.
- Joanne Waldstreicher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of hyperandrogenic conditions
- Patent number 5,932,559
- Issue date Aug 3, 1999
- Merck & Co., Inc.
- Herb G. Bull
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
17-alkyl-7-substituted-4-aza steroid derivatives as 5-.alpha.-reduc...
- Patent number 5,763,361
- Issue date Jun 9, 1998
- Merck & Co., Inc.
- Georgianna Harris
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of hyperandrogenic conditions
- Patent number 5,756,480
- Issue date May 26, 1998
- Merck & Co., Inc.
- Herb G. Bull
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
7.beta.-substituted-4-aza-5.alpha.-androstan-3-ones as 5.alpha.-red...
- Patent number 5,710,275
- Issue date Jan 20, 1998
- Merck & Co., Inc.
- Raman K. Bakshi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of hyperandrogenic conditions
- Patent number 5,656,613
- Issue date Aug 12, 1997
- Merck & Co., Inc.
- Herb G. Bull
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
7.beta.-substituted-4-aza-5.alpha.-cholestan-3-ones as 5.alpha. red...
- Patent number 5,527,807
- Issue date Jun 18, 1996
- Merck & Co., Inc.
- Raman K. Bakshi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Cyclic GMP dependent protein kinase as a chemotherapeutic target fo...
- Publication number 20070009979
- Publication date Jan 11, 2007
- Anne Gurnett
- G01 - MEASURING TESTING
Information Patent Application
Cyclic GMP dependent protien kinase as a chemotherapeutic target fo...
- Publication number 20030211552
- Publication date Nov 13, 2003
- Anne Gurnett
- G01 - MEASURING TESTING

Georgianna S. Harris

Person

Patents Grantslast 30 patents

Toxoplasma gondii cylclic GMP dependent protein kinase G as a chemo...

Cyclic GMP dependent protein kinase as a chemotherapeutic target fo...

Polynucleotide encoding eimeria tenella cGMP dependent protein kinase

Method of improving in-vitro fertilization

Irreversible inhibition of human 5.alpha.-reductase

Methods for treating polycystic ovary syndrome

Treatment of hyperandrogenic conditions

17-alkyl-7-substituted-4-aza steroid derivatives as 5-.alpha.-reduc...

Treatment of hyperandrogenic conditions

7.beta.-substituted-4-aza-5.alpha.-androstan-3-ones as 5.alpha.-red...

Treatment of hyperandrogenic conditions

7.beta.-substituted-4-aza-5.alpha.-cholestan-3-ones as 5.alpha. red...

Patents Applicationslast 30 patents

Cyclic GMP dependent protein kinase as a chemotherapeutic target fo...

Cyclic GMP dependent protien kinase as a chemotherapeutic target fo...